Daly Richard J 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Daly Richard J
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2026-01-05+42,105→ 281,843 total - Tax Payment
Common Stock, par value $0.001 per share
2026-01-05−10,577→ 271,266 total - Exercise/Conversion
Restricted Stock Units
2026-01-05−42,105→ 2,618,539 total→ Common Stock (42,105 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
- [F3]Derivative securities vest in equal tranches, 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027, 1/5th on January 1, 2028, and 1/5th on January 1, 2029.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on January 5, 2026.